4Filing Date: Jan 28, 2026
Becton Dickinson & (BDX)
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0001628280-26-003734
Total Value$15.2K
Trades1
Insiders1
Transaction Details
Feld Michael
EVP, CRO & Pres. Life Sciences·Direct
Sell · Dispose
Common Stock
Shares-75
Price$202.73
Total Value$15.2K
Shares Owned After16.43K
Transaction DateJan 26, 2026
10b5-1
Post-Transaction Holdings
Feld Michael · EVP, CRO & Pres. Life Sciences
| Security | Shares | Change |
|---|---|---|
| Common Stock | 16.43K | -75 (-0.45%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-01-26
10b5-1 Pre-arranged Plan: Yes
--- Issuer ---
Name: BECTON DICKINSON & CO (BDX)
CIK: 0000010795
--- Reporting Owner ---
Name: Feld Michael
CIK: 0002034349
Role: Officer (EVP, CRO & Pres. Life Sciences)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-01-26 | Code: S (Open market sale)
Shares: -75 | Price: $202.73
Total Value: $15,204.75
Shares Owned After: 16,431 | Ownership: D (Direct)
--- Signature ---
/s/ Donna Kalazdy, by power of attorney from Michael Feld (2026-01-28)